The Washington State Plan to Address Alzheimer’s Disease and Other Dementias sets out visionary goals and recommendations on raising awareness, ensuring early and accurate diagnosis and treatment, and improving supports and services for families.

Read More

Categories: Resources, News, Dementia Friends

Katie will manage and continue to support the expansion of the much-needed public outreach and awareness program throughout Washington state.

Read More

Categories: Team Spotlights, News, Dementia Friends, Dementia-Friendly Community, Memory Hub Spotlight

Kick off the new year with a hike in the Pacific Northwest, an experience tailored for people with younger onset Alzheimer’s disease.

Read More

Categories: Resources, Nature, Programs

The drug has been shown to reduce cognitive decline in patients with early Alzheimer's.

Read More

Categories: Science Updates, New FDA Drug Approvals, News

Our team had the privilege of working with the late Ka’imi Alohilani Sinclair (Western Cherokee) to create educational resources about Alzheimer’s disease and research, along with others at Washington State University's IREACH.

Read More

Categories: Team Spotlights, ADRC Indigenous Aging Brain Health Series, News

For these studies, researchers used data from participants in the UW ADRC Clinical Core, with gratitude.

Read More

Categories: Science Updates, News

Dr. Angela Hanson's lab team reports back on interesting talks about what’s coming soon in diagnosis, treatment, and prevention of Alzheimer’s and other diseases that lead to cognitive impairment and dementia.

Read More

Categories: Science Updates, New FDA Drug Approvals, Care & Treatment , News

Pull out a pencil for the very first Memory & Brain crossword puzzle, created to be fun, interesting—and just challenging enough—to be a good brain health workout.

Read More

Categories: Resources, News

Michael Rosenbloom, MD is a behavioral neurologist and the director of clinical trials for the UW Memory and Brain Wellness Center at the UW ADRC

Read More

Categories: New FDA Drug Approvals, Care & Treatment , Team Spotlights, News

La idea era reunir a miembros de la comunidad académica para entablar conversaciones y ayudar a dirigir la participación en la investigación de la Enfermedad de Alzheimer para incluir la representación de grupos minorizados.

Read More

Categories: En Español , News